Analyst Expects Atara Biotherapeutics Inc (NASDAQ: ATRA) To Make Big Moves

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Earlier, Yahoo Finance discussed this stock as it revealed Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

As a NASDAQ listed company, ATRA falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Atara Biotherapeutics Inc is $89.66M. A total of 1.2 million shares were traded on the day, compared to an average of 3.19M shares.

In the most recent transaction, Touchon Pascal sold 24,844 shares of ATRA for 0.72 per share on Mar 04 ’24. After the transaction, the President and CEO now owns 1,910,652 company shares. In a previous transaction on Mar 04 ’24, Nguyen AnhCo sold 10,746 shares at 0.72 per share. ATRA shares that EVP, Chief Sci. & Tech Officer owns now total 941,397.

Among the insiders who sold shares, Murugan Amar disposed of 10,044 shares on Mar 04 ’24 at a per-share price of $0.72. This resulted in the EVP, Chief Legal Officer holding 727,521 shares of ATRA after the transaction. In another insider transaction, Henrich Jill sold 3,879 shares at $0.72 per share on Mar 04 ’24. Company shares held by the EVP, Global Head RA & Quality now total 555,001.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ATRA has a high of $3.08 and a low of $0.20.

As of this writing, ATRA has an earnings estimate of -$0.42 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.62.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ATRA’s latest balance sheet shows that the firm has $371.07M in Cash & Short Term Investments as of fiscal 2021. There were $28.27M in debt and $105.79M in liabilities at the time. Its Book Value Per Share was -$0.93, while its Total Shareholder’s Equity was $279.61M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ATRA is Buy with a score of 3.00.

Most Popular

Related Posts